tirzepatide creatinine In a patient with type 2 diabetes on (Mounjaro) whose serum increased from 1.1 mg/dL (estimated glomerular filtration rate 52 mL/min/1.73 m²) to 1.4 mg/dL (estimated glomerular filtration rate 39 mL/min/1.73 m²) Tirzepatide — CRL

Newly published research is the latest to suggest that semaglutide and other GLP-1 drugs can help treat peoples addiction to both opioids and alcohol

In lupus, this autophagy pathway becomes hyperactivated, leading to excessive processing and presentation of self-antigens that fuel the autoimmune response

What the Numbers Show Average weight loss by timepoint: Week 12: 8.7% total body weight (19 pounds for 220-pound person) Week 24: 17.3% total body weight (38 pounds for 220-pound person) Week 36: 21.1% total body weight (46 pounds for 220-pound person) Week 48: 24.2% total body weight (53 pounds for 220-pound person) Data from Phase 2 clinical trial, 12mg dose cohort

Copyright Innerbody Research 1997 - 2025

Both drug classes are recognised in NICE guidance for type 2 diabetes management, though careful monitoring and patient education regarding side effects are essential

The GLP-1 Journal is built for exactly this